High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma

We report a novel group of clinically aggressive spinal cord ependymomas characterized by Grade III histology, MYCN amplification, an absence of NF2 alterations or other recurrent pathogenic mutations, and a unique methylation classifier profile. Seven cases were found to have MYCN amplification in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Acta Neuropathol Commun
Autores principales: Raffeld, Mark, Abdullaev, Zied, Pack, Svetlana D., Xi, Liqiang, Nagaraj, Sushma, Briceno, Nicole, Vera, Elizabeth, Pittaluga, Stefania, Lopes Abath Neto, Osorio, Quezado, Martha, Aldape, Kenneth, Armstrong, Terri S., Gilbert, Mark R.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7346356/
https://ncbi.nlm.nih.gov/pubmed/32641156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-020-00973-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares